BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22816737)

  • 21. Nodal and splenic marginal zone B cell lymphomas.
    Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
    Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.
    Traverse-Glehen A; Bachy E; Baseggio L; Callet-Bauchu E; Gazzo S; Verney A; Hayette S; Jallades L; Ffrench M; Salles G; Coiffier B; Felman P; Berger F
    Histopathology; 2013 May; 62(6):876-93. PubMed ID: 23611359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.
    Clipson A; Wang M; de Leval L; Ashton-Key M; Wotherspoon A; Vassiliou G; Bolli N; Grove C; Moody S; Escudero-Ibarz L; Gundem G; Brugger K; Xue X; Mi E; Bench A; Scott M; Liu H; Follows G; Robles EF; Martinez-Climent JA; Oscier D; Watkins AJ; Du MQ
    Leukemia; 2015 May; 29(5):1177-85. PubMed ID: 25428260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
    Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
    Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.
    Martínez N; Almaraz C; Vaqué JP; Varela I; Derdak S; Beltran S; Mollejo M; Campos-Martin Y; Agueda L; Rinaldi A; Kwee I; Gut M; Blanc J; Oscier D; Strefford JC; Martinez-Lopez J; Salar A; Sole F; Rodriguez-Peralto JL; Diez-Tascón C; García JF; Fraga M; Sebastián E; Alvés J; Menárguez J; González-Carreró J; Casado LF; Bayes M; Bertoni F; Gut I; Piris MA
    Leukemia; 2014 Jun; 28(6):1334-40. PubMed ID: 24296945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel genomic imbalances in B-cell splenic marginal zone lymphomas revealed by comparative genomic hybridization and cytogenetics.
    Hernández JM; García JL; Gutiérrez NC; Mollejo M; Martínez-Climent JA; Flores T; González MB; Piris MA; San Miguel JF
    Am J Pathol; 2001 May; 158(5):1843-50. PubMed ID: 11337382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Translocation t(9;14)(p13;q32) in cases of splenic marginal zone lymphoma.
    Baró C; Salido M; Domingo A; Granada I; Colomo L; Serrano S; Solé F
    Haematologica; 2006 Sep; 91(9):1289-91. PubMed ID: 16956840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
    Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
    Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
    Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
    Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
    Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Splenic marginal zone B-cell lymphomas: two cytogenetic subtypes, one with gain of 3q and the other with loss of 7q.
    Solé F; Salido M; Espinet B; Garcia JL; Martinez Climent JA; Granada I; Hernández JM; Benet I; Piris MA; Mollejo M; Martinez P; Vallespí T; Domingo A; Serrano S; Woessner S; Florensa L
    Haematologica; 2001 Jan; 86(1):71-7. PubMed ID: 11146574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Splenic marginal zone B-cell lymphoma: a distinct clinicopathological and molecular entity. Recent advances in ontogeny and classification.
    Traverse-Glehen A; Baseggio L; Salles G; Felman P; Berger F
    Curr Opin Oncol; 2011 Sep; 23(5):441-8. PubMed ID: 21760505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.
    Parry M; Rose-Zerilli MJ; Ljungström V; Gibson J; Wang J; Walewska R; Parker H; Parker A; Davis Z; Gardiner A; McIver-Brown N; Kalpadakis C; Xochelli A; Anagnostopoulos A; Fazi C; de Castro DG; Dearden C; Pratt G; Rosenquist R; Ashton-Key M; Forconi F; Collins A; Ghia P; Matutes E; Pangalis G; Stamatopoulos K; Oscier D; Strefford JC
    Clin Cancer Res; 2015 Sep; 21(18):4174-4183. PubMed ID: 25779943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Splenic marginal zone lymphoma.
    Oscier D; Owen R; Johnson S
    Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma.
    Gazzo S; Chudoba I; Traverse-Glehen A; Baseggio L; Felman P; Berger F; Salles G; Hayette S; Magaud JP; Callet-Bauchu E
    Cancer Genet Cytogenet; 2007 Jun; 175(2):159-65. PubMed ID: 17556073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Splenic marginal zone lymphomas appear to originate from different B cell types.
    Bahler DW; Pindzola JA; Swerdlow SH
    Am J Pathol; 2002 Jul; 161(1):81-8. PubMed ID: 12107092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
    Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
    Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.